This year’s government work report made to the development of medicine, the national pharmaceutical industry. How to promote Chinese medicine to the world? March 8, the CPPCC National Committee, the State Administration of Traditional Science and Technology Secretary TRADITIONAL National People’s Congress Chairman Yuan Group Co., Ltd. Jiangsu Kang Xiao Wei, the CPPCC National Committee, Tianjin Darren Hall pharmaceutical Jingwanhong Liuwen Wei, general manager, guest “after two sessions of the night”, around this topic in depth.
TRADITIONAL members said, are areas of strength in the pharmaceutical industry with independent intellectual property rights of thousands of years to form, and Chinese medicine not only for the health of the Chinese people to contribute to the world and also had a profound impact on medicine. Especially into the “Eleventh Five-Year” since the state attaches great importance to the world of medicine, chief researcher at the Chinese Academy of Traditional Chinese Medicine, Professor Tu Yo Yo won the Nobel Prize in Physiology or Medicine last year, more attracted worldwide attention to Chinese medicine. The country has just recently issued the “Strategic Plan for Development of Traditional Chinese Medicine (2016- 2030),” clearly put forward to promote overseas development of Chinese medicine, Chinese medicine to the world, the international trade as a key Chinese medicine, Chinese medicine on the one hand “going out” for human health services, in addition to “bring in”, the use of advanced science and technology and development experience around the world integrate, to jointly promote the traditional Chinese medicine for human health services.
“Chinese medicine ‘going out’ is our medicine man’s dream.” Liuwen Wei members felt that the clinical efficacy of Chinese Medical Herb medicine in surgery medication intuitive, less interfering factors, easy to evaluate, with Western medicine for external use do not have a significant comparative advantage . Therefore, Chinese medicine “going out” for external use Chinese medicine should start.
“But the Chinese medicine to the world also faces three barriers.” TRADITIONAL members said specifically that cultural barriers, technical barriers, medical services inherit and carry forward the barriers.
How to break these three barriers? TRADITIONAL members felt that, first, the state should vigorously promote the standardization of traditional Chinese medicine, the right to speak. For example, in the diagnosis of the disease, Chinese medicine to promote the construction of the International Classification of Disease ICD11 codes. Second, the standardization of traditional Chinese medicine treatment, enterprises should also motivated. Xiao Wei expressed that traditional Chinese medicine standards more complex and requires from the dynamic and static aspects of the development of the formation of two series of standards, “we all agree that only the formation of the standards in order to further tap the name of party-name drugs.”
TRADITIONAL members said, the State Administration of Traditional Chinese Medicine to start soon standardization initiatives. Traditional Chinese Medicine “going out”, local access to foreign markets, but also to meet their standards, respect for the local culture, get local recognition.
To break through the Chinese medicine “go out” barriers, Chinese enterprises should strengthen innovation.
“The real innovation is the driving force for enterprise development.” Xiao Wei on behalf of, the current Hong edge medicine whether it is innovative drugs, intellectual property rights or patent drugs are the largest, but also faces great distress, “Our new drug after the difficult access to health insurance drug list, it is difficult to enter the list of new drugs. ”
Xiao Wei representative said that now in the Medicare drug developed 10 years ago, many of which are varieties of the past few years the State Food and Drug Administration approved the certificate of varieties entered not by much. This is not conducive to mobilizing the enthusiasm of innovative pharmaceutical companies.
“There is a problem to be solved, as long as the medicine tendering process, will be endless cut 15-20% of the price, including innovative drugs.” Xiao Wei representative said the company in Hunan, Anhui and other provinces of losing, the main the province is in the bidding process discriminate against Chinese medicines policy, go on like this, then, traditional Chinese medicine market will be marginalized.